{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T20:08:10Z","timestamp":1789243690074,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA273924"],"award-info":[{"award-number":["R01CA273924"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.intimp.2026.116788","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T17:37:28Z","timestamp":1778175448000},"page":"116788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["FcRn function alone cannot account for elevated IgG clearance in the Lewis lung carcinoma model of cancer cachexia"],"prefix":"10.1016","volume":"182","author":[{"given":"Adeoluwa","family":"Adeluola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Remaily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiliang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyeongmin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra D.","family":"Partey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Hai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Hoelzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seolbin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faith","family":"Jeffrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melisa","family":"Bilgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Stanton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Dickess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Granchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel K.","family":"Kulp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwight H.","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo","family":"Xiaokui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latha P.","family":"Ganesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Mace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitch A.","family":"Phelps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Coss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.intimp.2026.116788_bb0005","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2026.116788_bb0010","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/s41392-023-01522-4","article-title":"Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"19","key":"10.1016\/j.intimp.2026.116788_bb0015","doi-asserted-by":"crossref","first-page":"12293","DOI":"10.1073\/pnas.192461099","article-title":"Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade","volume":"99","author":"Iwai","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.intimp.2026.116788_bb0020","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41422-020-0343-4","article-title":"Immune checkpoint signaling and cancer immunotherapy","volume":"30","author":"He","year":"2020","journal-title":"Cell Res."},{"issue":"5","key":"10.1016\/j.intimp.2026.116788_bb0025","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.3390\/curroncol29050247","article-title":"Immune checkpoint inhibitors in cancer therapy","volume":"29","author":"Shiravand","year":"2022","journal-title":"Curr. Oncol."},{"issue":"4","key":"10.1016\/j.intimp.2026.116788_bb0030","first-page":"381","article-title":"Ipilimumab and cancer immunotherapy: a new hope for advanced stage melanoma","volume":"84","author":"Mansh","year":"2011","journal-title":"Yale J. Biol. Med."},{"issue":"7","key":"10.1016\/j.intimp.2026.116788_bb0035","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s40262-019-00748-2","article-title":"Clinical pharmacokinetics and pharmacodynamics of immune checkpoint inhibitors","volume":"58","author":"Centanni","year":"2019","journal-title":"Clin. Pharmacokinet."},{"issue":"4","key":"10.1016\/j.intimp.2026.116788_bb0040","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"issue":"23","key":"10.1016\/j.intimp.2026.116788_bb0045","doi-asserted-by":"crossref","first-page":"5841","DOI":"10.1158\/1078-0432.CCR-18-0415","article-title":"Pembrolizumab exposure-response assessments challenged by Association of Cancer Cachexia and Catabolic Clearance","volume":"24","author":"Turner","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2026.116788_bb0050","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s40425-016-0177-2","article-title":"Nivolumab dose selection: challenges, opportunities, and lessons learned for cancer immunotherapy","volume":"4","author":"Agrawal","year":"2016","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.intimp.2026.116788_bb0055","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejca.2019.02.017","article-title":"Letter to the editor: exposure-response or clearance-response relationship in immune checkpoint therapy?-A comment on 'correlation between nivolumab exposure and treatment outcomes in non-small-cell lung cancer' by Basak et al","volume":"114","author":"Badawi","year":"2019","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.intimp.2026.116788_bb0060","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1158\/1078-0432.CCR-23-1683","article-title":"Antibody drug clearance: an underexplored marker of outcomes with checkpoint inhibitors","volume":"30","author":"Guo","year":"2024","journal-title":"Clin. Cancer Res."},{"issue":"23","key":"10.1016\/j.intimp.2026.116788_bb0065","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.1158\/1078-0432.CCR-18-1847","article-title":"Cachectic cancer patients: immune to checkpoint inhibitor therapy?","volume":"24","author":"Coss","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.intimp.2026.116788_bb0070","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/cpt.3513","article-title":"Impact of chronic inflammatory diseases on clinical pharmacokinetics of antibody-based therapeutic proteins","volume":"117","author":"Tian","year":"2025","journal-title":"Clin. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.intimp.2026.116788_bb0075","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/rco2.32","article-title":"Murine cancer cachexia models replicate elevated catabolic pembrolizumab clearance in humans","volume":"4","author":"Castillo","year":"2021","journal-title":"JCSM Rapid Commun."},{"issue":"1","key":"10.1016\/j.intimp.2026.116788_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/rco2.117","article-title":"Intramuscular CMT-167 Tumors produce a mild Cachexia phenotype in C57BL\/6J mice","volume":"8","author":"Remaily","year":"2025","journal-title":"JCSM Commun"},{"key":"10.1016\/j.intimp.2026.116788_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.107048","article-title":"Decoupling FcRn and tumor contributions to elevated immune checkpoint inhibitor clearance in cancer cachexia","volume":"199","author":"Vu","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"7","key":"10.1016\/j.intimp.2026.116788_bb0090","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.4049\/jimmunol.179.7.4580","article-title":"Neonatal FcR expression in bone marrow-derived cells functions to protect serum IgG from catabolism","volume":"179","author":"Akilesh","year":"2007","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2026.116788_bb0095","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41577-022-00821-1","article-title":"The therapeutic age of the neonatal fc receptor","volume":"23","author":"Pyzik","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116788_bb0100","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1080\/19420862.2018.1458808","article-title":"Hematopoietic cells as site of first-pass catabolism after subcutaneous dosing and contributors to systemic clearance of a monoclonal antibody in mice","volume":"10","author":"Richter","year":"2018","journal-title":"MAbs"},{"issue":"5","key":"10.1016\/j.intimp.2026.116788_bb0105","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1080\/19420862.2019.1602459","article-title":"Neonatal fc receptor expression in macrophages is indispensable for IgG homeostasis","volume":"11","author":"Challa","year":"2019","journal-title":"MAbs"},{"issue":"2","key":"10.1016\/j.intimp.2026.116788_bb0110","first-page":"C606","article-title":"The complex heterogeneity of immune cell signatures across wasting tissues with C26 and 5-fluorouracil-induced cachexia","volume":"326","author":"VanderVeen","year":"2024","journal-title":"Am. J. Phys. Cell Phys."},{"issue":"3","key":"10.1016\/j.intimp.2026.116788_bb0115","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00441-004-0987-2","article-title":"Adipose tissue in Walker 256 tumour-induced cachexia: possible association between decreased leptin concentration and mononuclear cell infiltration","volume":"318","author":"Machado","year":"2004","journal-title":"Cell Tissue Res."},{"issue":"3","key":"10.1016\/j.intimp.2026.116788_bb0120","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/JOE-12-0307","article-title":"Heterogeneous time-dependent response of adipose tissue during the development of cancer cachexia","volume":"215","author":"Batista","year":"2012","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.intimp.2026.116788_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1669979","article-title":"Tumor intrinsic properties dictate fc receptor expression and cancer cachexia associated increase in checkpoint inhibitor clearance","volume":"16","author":"Remaily","year":"2025","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2026.116788_bb0130","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/SPC.0000000000000380","article-title":"Understanding sex differences in the regulation of cancer-induced muscle wasting","volume":"12","author":"Montalvo","year":"2018","journal-title":"Curr. Opin. Support. Palliat. Care"},{"issue":"6","key":"10.1016\/j.intimp.2026.116788_bb0135","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s11914-020-00628-w","article-title":"Sex differences in cancer cachexia","volume":"18","author":"Zhong","year":"2020","journal-title":"Curr. Osteoporos. Rep."},{"issue":"8","key":"10.1016\/j.intimp.2026.116788_bb0140","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1080\/19420862.2017.1375639","article-title":"Modulation of protein a binding allows single-step purification of mouse bispecific antibodies that retain FcRn binding","volume":"9","author":"Zwolak","year":"2017","journal-title":"MAbs"},{"issue":"13","key":"10.1016\/j.intimp.2026.116788_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23137066","article-title":"The neonatal Fc receptor is elevated in monocyte-derived immune cells in pancreatic cancer","volume":"23","author":"Thomas","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116788_bb0150","article-title":"Myeloid cell isolation from mouse skin and draining lymph node following intradermal immunization with live attenuated Plasmodium sporozoites","volume":"111","author":"Mac-Daniel","year":"2016","journal-title":"J. Vis. Exp."},{"issue":"5","key":"10.1016\/j.intimp.2026.116788_bb0155","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/FTD.0000000000000534","article-title":"Development of an enzyme-linked immune sorbent assay to measure nivolumab and pembrolizumab serum concentrations","volume":"40","author":"Basak","year":"2018","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.intimp.2026.116788_bb0160","series-title":"Quantification and analysis of proteins","first-page":"231","author":"Shen","year":"2023"},{"issue":"9","key":"10.1016\/j.intimp.2026.116788_bb0165","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4103\/1947-2714.100998","article-title":"Western blot: technique, theory, and trouble shooting","volume":"4","author":"Mahmood","year":"2012","journal-title":"N. Am. J. Med. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2026.116788_bb0170","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10928-020-09695-z","article-title":"Prior information for population pharmacokinetic and pharmacokinetic\/pharmacodynamic analysis: overview and guidance with a focus on the NONMEM PRIOR subroutine","volume":"47","author":"Chan Kwong","year":"2020","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"issue":"5","key":"10.1016\/j.intimp.2026.116788_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13051059","article-title":"Bone marrow homeostasis is impaired via JAK\/STAT and glucocorticoid signaling in cancer cachexia model","volume":"13","author":"Yu","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.intimp.2026.116788_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114925","article-title":"Muscle inflammation is regulated by NF-\u03baB from multiple cells to control distinct states of wasting in cancer cachexia","volume":"43","author":"Pryce","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.intimp.2026.116788_bb0185","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.canlet.2020.04.017","article-title":"Macrophages potentiate STAT3 signaling in skeletal muscles and regulate pancreatic cancer cachexia","volume":"484","author":"Shukla","year":"2020","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.intimp.2026.116788_bb0190","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ccell.2024.03.009","article-title":"The crosstalk between macrophages and cancer cells potentiates pancreatic cancer cachexia","volume":"42","author":"Liu","year":"2024","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.intimp.2026.116788_bb0195","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2165\/11531280-000000000-00000","article-title":"Clinical pharmacokinetics of therapeutic monoclonal antibodies","volume":"49","author":"Keizer","year":"2010","journal-title":"Clin. Pharmacokinet."},{"issue":"6","key":"10.1016\/j.intimp.2026.116788_bb0200","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/cts.12567","article-title":"Tutorial on monoclonal antibody pharmacokinetics and its considerations in early development","volume":"11","author":"Ovacik","year":"2018","journal-title":"Clin. Transl. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2026.116788_bb0205","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4161\/mabs.4.1.18543","article-title":"Subcutaneous bioavailability of therapeutic antibodies as a function of FcRn binding affinity in mice","volume":"4","author":"Deng","year":"2012","journal-title":"MAbs"},{"key":"10.1016\/j.intimp.2026.116788_bb0210","first-page":"249","article-title":"FcRn: from molecular interactions to regulation of IgG pharmacokinetics and functions","volume":"382","author":"Challa","year":"2014","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.intimp.2026.116788_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01540","article-title":"The neonatal fc receptor (FcRn): a misnomer?","volume":"10","author":"Pyzik","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116788_bb0220","doi-asserted-by":"crossref","unstructured":"J. Thomas, et al., The neonatal FC receptor is elevated in monocyte-derived immune cells in pancreatic cancer, J. Immunother. Cancer (2021) BMJ publishing group british medical association house, Tavistock Square, London WC1H, vol (9), Suppl_2, Pages: A706\u2013A706.","DOI":"10.1136\/jitc-2021-SITC2021.678"},{"issue":"19","key":"10.1016\/j.intimp.2026.116788_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/nu17193064","article-title":"Cachexia in pancreatic cancer: new insights to impact quality of life and survival","volume":"17","author":"Yoon","year":"2025","journal-title":"Nutrients"},{"issue":"16","key":"10.1016\/j.intimp.2026.116788_bb0230","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1182\/blood-2008-09-179754","article-title":"Specificity and affinity of human Fc\u03b3 receptors and their polymorphic variants for human IgG subclasses","volume":"113","author":"Bruhns","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2026.116788_bb0235","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2026.116788_bb0240","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.4049\/jimmunol.1400580","article-title":"Resident alveolar macrophages suppress, whereas recruited monocytes promote, allergic lung inflammation in murine models of asthma","volume":"193","author":"Zas\u0142ona","year":"2014","journal-title":"J. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.intimp.2026.116788_bb0245","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijpharm.2012.09.042","article-title":"Application of knockout mouse models to investigate the influence of Fc\u03b3R on the tissue distribution and elimination of 8C2, a murine IgG1 monoclonal antibody","volume":"439","author":"Abuqayyas","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.intimp.2026.116788_bb0250","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.13869","article-title":"Loss of expression of the recycling receptor, FcRn, promotes tumor cell growth by increasing albumin consumption","volume":"8","author":"Swiercz","year":"2016","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.intimp.2026.116788_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13081946","article-title":"The role of macrophages in cancer development and therapy","volume":"13","author":"Cendrowicz","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.intimp.2026.116788_bb0260","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.799428","article-title":"Tumor-associated macrophages: critical players in drug resistance of breast cancer","volume":"12","author":"Xiao","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116788_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1658795","article-title":"Progress in targeting tumor-associated macrophages in cancer immunotherapy","volume":"16","author":"Xia","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116788_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1054425","article-title":"The neonatal fc receptor expression during macrophage differentiation is related to autophagy","volume":"13","author":"Lamamy","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116788_bb0275","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00303","article-title":"Macrophage polarization modulates Fc\u03b3R- and CD13-mediated phagocytosis and reactive oxygen species production, independently of receptor membrane expression","volume":"8","author":"Mendoza-Coronel","year":"2017","journal-title":"Front. Immunol."},{"issue":"22","key":"10.1016\/j.intimp.2026.116788_bb0280","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212172","article-title":"There is strength in numbers: quantitation of fc gamma receptors on murine tissue-resident macrophages","volume":"22","author":"Vorsatz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.intimp.2026.116788_bb0285","doi-asserted-by":"crossref","first-page":"901","DOI":"10.6061\/clinics\/2012(08)08","article-title":"M2-polarized macrophages promote metastatic behavior of Lewis lung carcinoma cells by inducing vascular endothelial growth factor-C expression","volume":"67","author":"Zhang","year":"2012","journal-title":"Clinics"},{"issue":"5","key":"10.1016\/j.intimp.2026.116788_bb0290","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/jcsm.12450","article-title":"Macrophages protect against loss of adipose tissue during cancer cachexia","volume":"10","author":"Erdem","year":"2019","journal-title":"J. Cachexia. Sarcopenia Muscle"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692600634X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757692600634X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T19:58:26Z","timestamp":1789243106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757692600634X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":58,"alternative-id":["S156757692600634X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116788","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FcRn function alone cannot account for elevated IgG clearance in the Lewis lung carcinoma model of cancer cachexia","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116788","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116788"}}